Enrichment of sequencing targets from the human genome by solution hybridizationDevelopment of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patientsAssessing the impact of population stratification on genetic association studiesEric Topol: The wireless future of medicineGain-of-function ADCY5 mutations in familial dyskinesia with facial myokymiaRare coding variants in the phospholipase D3 gene confer risk for Alzheimer's diseaseMechanism and effect of thrombospondin-4 polymorphisms on neutrophil functionThrombospondin-4 and its variants: expression and differential effects on endothelial cellsIdentification of four gene variants associated with myocardial infarction.Fluid phase biopsy for detection and characterization of circulating endothelial cells in myocardial infarctionMutation of MEF2A in an inherited disorder with features of coronary artery diseaseCox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitorsDebate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fightSystematic adjudication of myocardial infarction end-points in an international clinical trialDisagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT studyTowards precise classification of cancers based on robust gene functional expression profilesNovel wireless devices for cardiac monitoringAnnotating individual human genomesCystic fibrosis in an era of genomically guided therapyStop the privatization of health dataA laboratory in your pocketPrediction of Causal Candidate Genes in Coronary Artery Disease LociMoving From Digitalization to Digitization in Cardiovascular Care: Why Is it Important, and What Could it Mean for Patients and Providers?Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET)Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty StudyInternational variation in the use of evidence-based medicines for acute coronary syndromesTriple antiplatelet therapy does not increase femoral access bleeding with vascular closure devicesOral glycoprotein IIb/IIIa inhibitors: why don't they work?Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic eventsAdjunctive therapy for percutaneous revascularization in acute myocardial infarctionPercutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromesAspirin dose and six-month outcome after an acute coronary syndromeConvergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteinsComparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trialAnalysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trialsSuperiority of clopidogrel versus aspirin in patients with prior cardiac surgeryIncreased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trialsTiclopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) TrialIntegrin alphaIIbbeta3 and its antagonism
P50
Q21183896-72DF1769-0DA0-45BD-A747-C33FEC839D92Q21202033-D2AE0173-7A9D-4616-9C48-5DF9B8165CBCQ22337235-F025D6D8-C6B1-4D46-A9CA-B57565E62418Q22976994-E64E0983-6C1A-401C-947C-F5F88C7581DDQ24293635-8224D389-5810-4E51-AF78-D65BD7BCF035Q24312938-88E73E3E-2A64-4004-9E2E-1FE63B3E63D6Q24314830-6C263C74-4E6E-49AB-AE76-4D51374E5B87Q24319267-97FFEBD5-3C55-4E76-AC5E-8C7AB7984F9CQ24536320-B9F38EDA-CF60-4548-AADC-50AD7F5DC641Q24564065-567EEDCA-F7F1-49EF-A21B-097B9DA1B9B3Q24669679-AA6D59D1-489F-4AE2-9B92-F605F6114950Q24796005-B3C0C98D-C437-4D91-AE95-4355E092FA6CQ24799198-F189ED0E-8A46-4567-9664-2EDEB9E640C3Q24805625-F815D053-F277-49B2-B6C5-87C4437DB161Q24805692-CA48F83A-6BD2-4FED-AEDF-54ED4E00AF6CQ24811476-019DA78C-8523-4187-AEDD-AD06726F6681Q26828642-7F06D7AE-C324-4E4D-9612-64BF0B7C438AQ26999723-0CBBAC32-F9DA-470E-9136-6B893A72987BQ27003971-D4B509A1-2A79-4E7B-AD49-2DA7F84A83D7Q27132103-6bf1b4ea-4ece-55d3-2a6c-8ef11f7f6e5cQ27276923-D25B41FD-FD2F-42A2-B4B1-5FF9FAB9C610Q27276923-E365ECAB-AF2C-4977-8CC7-BDE68A88E4F1Q27342192-EE4999B7-07CF-48F4-A477-C0311AA47763Q28084558-CA4D0AE7-FDF0-4A60-B6A9-B15B93937883Q28165540-8DEFD409-EA41-4DE8-A751-061BEBFF1DB8Q28165755-CD69BBB0-99DA-479E-BA01-9DAB00E3AA22Q28166289-DEE95DB1-A0F3-4683-AD8A-9BAA2004072CQ28166576-4AD61A86-C009-4DE7-AE7E-7F824A5504A7Q28166805-3E1CCAF1-37CE-48C0-901E-F78DDAB0BEF7Q28166805-77EEAE9A-B1FA-47C2-8288-FAADCA36EF21Q28166894-7B213407-3C77-42F5-B2C1-2961E5863B57Q28167253-ECD5AD3C-4345-406C-B11A-93EAF06DE424Q28167317-F148D05B-D498-4058-A98A-A7D6A9A0F441Q28167843-4458B6B6-2ADF-4BBC-8A9D-5EAC0DD524A7Q28168105-68D20489-7B3A-49C1-A7CD-A8077BB4406FQ28168414-7C975877-30F9-471C-A383-5E179BA31C84Q28170627-5C2C81EA-8D14-4D7B-AE06-0A489A33F7AEQ28174968-AD7C66E2-9B33-4E3C-9F99-E21146E2CF85Q28175229-FE5E4CCC-0434-4F4C-92AC-3F3D81DD5287Q28176219-3FCF3DEC-290B-4CC2-A70D-00CE44D2DC15
P50
description
American cardiologist
@en
Cardiólogo estadounidense
@es
US-amerikanischer Kardiologe und Autor
@de
cairdeolaí Meiriceánach
@ga
cardiolojiste american
@lfn
usona kardiologo
@eo
美国医学家
@zh
美国医学家
@zh-hans
name
Eric Topol
@ast
Eric Topol
@ca
Eric Topol
@de
Eric Topol
@en
Eric Topol
@es
Eric Topol
@fr
Eric Topol
@ga
Eric Topol
@it
Eric Topol
@nl
Eric Topol
@pl
type
label
Eric Topol
@ast
Eric Topol
@ca
Eric Topol
@de
Eric Topol
@en
Eric Topol
@es
Eric Topol
@fr
Eric Topol
@ga
Eric Topol
@it
Eric Topol
@nl
Eric Topol
@pl
altLabel
E J Topol
@en
E Topol
@en
E. J. Topol
@en
E. Topol
@en
Eric J Topol
@en
Eric J. Topol
@es
Eric Jeffrey Topol
@en
Topol E
@en
Topol E. J.
@en
Topol E.
@en
prefLabel
Eric Topol
@ast
Eric Topol
@ca
Eric Topol
@de
Eric Topol
@en
Eric Topol
@es
Eric Topol
@fr
Eric Topol
@ga
Eric Topol
@it
Eric Topol
@nl
Eric Topol
@pl